全文获取类型
收费全文 | 20221篇 |
免费 | 1364篇 |
国内免费 | 367篇 |
专业分类
耳鼻咽喉 | 396篇 |
儿科学 | 362篇 |
妇产科学 | 317篇 |
基础医学 | 3329篇 |
口腔科学 | 236篇 |
临床医学 | 1598篇 |
内科学 | 4469篇 |
皮肤病学 | 778篇 |
神经病学 | 1499篇 |
特种医学 | 1397篇 |
外科学 | 2605篇 |
综合类 | 134篇 |
一般理论 | 5篇 |
预防医学 | 699篇 |
眼科学 | 534篇 |
药学 | 1618篇 |
中国医学 | 262篇 |
肿瘤学 | 1714篇 |
出版年
2023年 | 121篇 |
2022年 | 420篇 |
2021年 | 684篇 |
2020年 | 388篇 |
2019年 | 510篇 |
2018年 | 602篇 |
2017年 | 505篇 |
2016年 | 775篇 |
2015年 | 1098篇 |
2014年 | 1253篇 |
2013年 | 1353篇 |
2012年 | 1947篇 |
2011年 | 1855篇 |
2010年 | 1215篇 |
2009年 | 986篇 |
2008年 | 1299篇 |
2007年 | 1156篇 |
2006年 | 1032篇 |
2005年 | 907篇 |
2004年 | 724篇 |
2003年 | 664篇 |
2002年 | 582篇 |
2001年 | 249篇 |
2000年 | 241篇 |
1999年 | 180篇 |
1998年 | 141篇 |
1997年 | 127篇 |
1996年 | 79篇 |
1995年 | 56篇 |
1994年 | 44篇 |
1993年 | 50篇 |
1992年 | 44篇 |
1991年 | 65篇 |
1990年 | 42篇 |
1989年 | 53篇 |
1988年 | 66篇 |
1987年 | 50篇 |
1986年 | 39篇 |
1985年 | 38篇 |
1984年 | 20篇 |
1983年 | 29篇 |
1982年 | 20篇 |
1981年 | 17篇 |
1980年 | 25篇 |
1979年 | 25篇 |
1978年 | 33篇 |
1977年 | 35篇 |
1976年 | 16篇 |
1975年 | 15篇 |
1973年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
An IFN-beta-albumin fusion protein that displays improved pharmacokinetic and pharmacodynamic properties in nonhuman primates. 总被引:6,自引:0,他引:6
Cynthia Sung Bernardetta Nardelli David W LaFleur Erich Blatter Marta Corcoran Henrik S Olsen Charles E Birse Oxana K Pickeral Junli Zhang Devanshi Shah Gordon Moody Solange Gentz Lisa Beebe Paul A Moore 《Journal of interferon & cytokine research》2003,23(1):25-36
The long half-life and stability of human serum albumin (HSA) make it an attractive candidate for fusion to short-lived therapeutic proteins. Albuferon (Human Genome Sciences [HGS], Inc., Rockville, MD) beta is a novel recombinant protein derived from a gene fusion of interferon-beta (IFN-beta ) and HSA. In vitro, Albuferon beta displays antiviral and antiproliferative activities and triggers the IFN-stimulated response element (ISRE) signal transduction pathway. Array analysis of 5694 independent genes in Daudi-treated cells revealed that Albuferon beta and IFN-beta induce the expression of an identical set of 30 genes, including 9 previously not identified. In rhesus monkeys administered a dose of 50 microg/kg intravenously (i.v.) or subcutaneously (s.c.) or 300 microg/kg s.c., Albuferon beta demonstrated favorable pharmacokinetic properties. Subcutaneous bioavailability was 87%, plasma clearance at 4.7-5.7 ml/h/kg was approximately 140-fold lower than that of IFN-beta, and the terminal half-life was 36-40 h compared with 8 h for IFN-beta. Importantly, Albuferon beta induced sustained increases in serum neopterin levels and 2',5' mRNA expression. At a molar dose equivalent to one-half the dose of IFN-beta, Albuferon beta elicited comparable neopterin responses and significantly higher 2',5'-OAS mRNA levels in rhesus monkeys. The enhanced in vivo pharmacologic properties of IFN-beta when fused to serum albumin suggest a clinical opportunity for improved IFN-beta therapy. 相似文献
92.
93.
Heme-hemopexin (2-10 microM) is used as a model for intravenous heme released in trauma, stroke, and ischemia-reperfusion. A transient increase in cellular protein oxidation occurs during receptor-mediated heme transport from hemopexin which is inhibited by the nonpermeable Cu(I) chelator, bathocuproinedisulfonate. Thus, participation of surface redox process involving Cu(I) generation are proposed to be linked to the induction of the protective proteins heme oxygenase-1 (HO-1) and metallothionein-1 (MT-1) by heme-hemopexin. The region (-153 to -42) in the proximal promoter of the mouse MT-1 gene responds to heme- and CoPP-hemopexin in transient transfection assays and contains metal-responsive elements for MTF-1 and an antioxidant-responsive element (ARE) overlapping a GC-rich E-box to which USF-1 and -2 bind. No decreases in DNA binding of the diamide-oxidation sensitive USF-1 and -2 occur upon exposure of cells to heme-hemopexin. MTF-1 and the ARE-binding proteins are relatively resistant to diamide oxidation and are induced approximately eight- and two-fold, respectively, by heme-hemopexin. BCDS prevents the nuclear translocation of MTF-1 by both heme- and CoPP-hemopexin complexes as well as MT-1 mRNA induction by CoPP-hemopexin. Thus, copper is needed for the surface oxidation events and yet the nuclear translocation of MTF-1 in response to hemopexin occurs via copper, probably Cu(I),-dependent signaling cascades from the hemopexin receptor rather than the oxidation per se. 相似文献
94.
Role of actin microfilament in osmotic stretch-induced increase of voltage-operated calcium channel current in guinea-pig gastric myocytes 总被引:5,自引:0,他引:5
Wen Xie Xu Sung Joon Kim Insuk So K. W. Kim 《Pflügers Archiv : European journal of physiology》1997,434(4):502-504
Using the whole-cell patch clamp technique, the role of actin microfilament in hyposmotic increase of voltage-operated calcium
channel current (I
Ba) was studied in guinea-pig gastric myocytes. Hyposmotic superfusate (212 mOsm) increased peak I
Ba amplitude by 32.7 ± 6.5%; when cytochalasin-D (Cyt-D, 20 μM), an actin cytoskeleton disruptor, was used, an increase of only
9.7 ± 3.1% was seen. I
Baresponse to osmotic stress was potentiated (45.1 ± 4.1% increase) by 20 μM phalloidin, an actin microfilament stabilizer.
However, colchicine (100 μM), an microtubule cytoskeleton disruptor, had no effect on either I
Ba or its response to hyposmotic solution. Phalloidin also induced a rightward shift of the I/V relationship of I
Ba, while Cyt-D itself had no effect. These results suggest that actin cytoskeleton may mediate hyposmotic stretch-induced I
Ba increase in gastric smooth muscle.
Received: 26 March 1997 / Received after revision: 28 May 1997 / Accepted: 3 June 1997 相似文献
95.
Jeong HJ Sung SH Hong SW Moon JI Kim SI Kim YS Park K 《Virchows Archiv : an international journal of pathology》2000,437(1):69-73
The distribution pattern of extracellular matrix (ECM) components in transplant glomerulopathy was studied in relation to
light microscopic features, actin expression of mesangial cells, and intraglomerular inflammatory cells. Nine cases of mild
(group I) and nine cases of severe (group II) transplant glomerulopathy were stained with antisera against fibronectin (FN),
tenascin (TN), collagen types III and IV, smooth muscle actin, CD45RO, CD68, and Ki-67 antigen. The composition of ECM was
similar in the two groups. The expanded mesangium was diffusely stained by type-IV collagen, FN and TN, and focally and weakly
stained by type-III collagen and smooth muscle actin. Type-IV collagen was linearly stained along the capillary walls, imparting
a double-contour feature, whereas FN and TN showed granular staining along the capillary walls. CD68 positive cells were increased
in severe transplant glomerulopathy, but this increase was not related to ECM deposition. These findings suggest that increased
glomerular deposition of normal and abnormal ECM components participate in the evolution of transplant glomerulopathy.
Received: 5 October 1999 / Accepted: 17 January 2000 相似文献
96.
Zier K Johnson K Maddux JM Sung M Mandeli J Eisenbach L Schwartz M 《Journal of immunological methods》2000,241(1-2):61-68
Several issues remain to be resolved before the efficacy of various approaches to elicit anti-tumor immunity in patients can be evaluated. First, in vitro assays able to detect responses by T cells primed in vivo are needed. Second, a source of tumor antigen to stimulate patients' lymphocytes in vitro is required. The ELISPOT assay is attractive, because it can be performed with a small numbers of cells and requires only short-term culture in vitro. A source of tumor antigen is more problematic, since for most tumors, tumor-associated antigens (TAA) have not been identified and/or cloned. In this report we demonstrate that autologous antigen-presenting cells (APC) pulsed with total tumor peptides from autologous tumor tissue can stimulate IFNgamma release by patients' lymphocytes in the ELISPOT assay. Thus, this approach should be considered for monitoring immune responses in clinical immunotherapy trials. 相似文献
97.
98.
We investigated the capacity of human interleukin (IL) 7 to induce proliferation of B cells. Purified tonsillar B cells were cultured in the presence of IL7 with Staphylococcus aureus Cowan I (SAC) or anti-μ beads as co-mitogens. IL 7 supported a dose-dependent proliferation of anti-μ-activated B cells but did not significantly support proliferation of SAC-activated B cells. When B cells were separated on Percoll gradient into small (60%-80%) and large (50%–60%) B cells and then cultured with anti-μ beads, IL7 acted on both cell populations equally well. IL7 and BCGF (low molecular weight) were synergistic in their proliferative action on anti-μ-activated B cells in a 5-day culture. On the other hand, synergistic effect of IL 7 on activated B cells was not evident in the presence of any other factor recombinant [(r)IL 1β, rIL2, rIL3, rIL4, rIL5, rIL6, recombinant tumor necrosis factor-α, recombinant lymphotoxin, recombinant granulocyte-monocyte colony-stimulating factor and recombinant interferon-γ] we tested. IL7 did not induce IgG secretion by activated B cells. 相似文献
99.
Kee HJ Shin JH Chang J Chung KY Shin DH Kim YS Kim SK Kim SK 《Yonsei medical journal》2003,44(1):65-74
Small cell lung cancer (SCLC) frequently shows a loss of heterozygosity (LOH) on chromosome 15q. In order to define the commonly affected region on chromosome 15q, we tested 23 primary SCLCs by microsatellite analysis. By analyzing 43 polymorphic microsatellite markers located on chromosome 15q, we found that 14 (60.8%) of 23 tumors exhibited a LOH in at least one of the tested microsatellite markers. Two (14.3%) of the 14 tumors were found to have more than a 50% LOH on chromosome 15q. LOH was observed in five commonly deleted regions on 15q. Of those regions, LOH from D15S1012 to D15S1016 was the most frequent (47.8%). LOH was also observed in more than 20-30% of tumors at four other regions, from D15S1031 to D15S1007, from D15S643 to D15S980, from D15S979 to D15S202, and from D15S652 to D15S642. Four of the 23 tumors exhibited shifted bands in at least one of the tested microsatellite markers. Shifted bands occurred in 3.2% (29 of 914) of the loci tested. Our data suggests the presence of at least five tumor suppressor loci on chromosome 15q in SCLC, and further that these may play an important role in SCLC tumorigenesis. 相似文献
100.
Sung L Shibata M Eskew JD Shipulina N Morales PJ Smith A 《Antioxidants & redox signaling》2000,2(4):753-765
A model has been developed for the hemopexin receptor-mediated heme transport system based on iron uptake in yeast. Two steps are required: reduction followed by oxidation by a multi-copper-oxidase. Furthermore, in the hemopexin system, the surface redox events have been linked with gene regulation. The impermeable Cu(I) chelator bathocuproinedisulfonate (BCDS) is shown here to abrogate heme oxygenase-1 (HO-1) mRNA induction by heme-hemopexin. A role for Cu(I) in the regulation of HO-1 and MT-1 (Sung et al., 1999) by hemopexin supports the participation of electron transport processes at the cell surface as does competition by the reductase activator, ferric citrate, which inhibits the induction of MT-1 and HO-1 mRNA by heme-hemopexin. There is a key role for the hemopexin receptor because neither ferric citrate nor iron-transferrin alone regulates MT-1 or HO-1. Cell-surface copper is the first molecule to link the concomitant regulation of HO-1 and MT-1 by the hemopexin receptor. In addition, cytochrome b5 and cytochrome b5 reductase are implicated here in the response of cells to heme-hemopexin. Reduction of one or more electron donors of the reductase and oxidation of the electron acceptor, b5 heme, leads to gene regulation, but only when heme-hemopexin is bound to its receptor. Protein kinase cascades, including JNK, are activated by the hemopexin receptor itself upon ligand binding but are modulated by a Cu(I)-dependent process likely to be heme uptake. 相似文献